AI Article Synopsis

  • Developing an efficient expression system for bacterial lytic enzymes is difficult because these enzymes target peptidoglycan in bacterial cell walls, which can lead to the lysis of the bacteria that produce them.
  • The paper discusses the creation of an inducible expression system in Pseudomonas fluorescens Q2-87 for lytic peptidases AlpA and AlpB from Lysobacter sp. XL1, allowing for successful secretion of these proteins into the culture medium.
  • The system uses a combination of a chromosomal endopeptidase gene under a T7lac promoter and a plasmid-borne phage T7 RNA polymerase, alongside optimized growth conditions to simplify the purification process, aiming to facilitate the

Article Abstract

Development of an efficient expression system for (especially secreted) bacterial lytic enzymes is a complicated task due to the specificity of their action. The substrate for such enzymes is peptidoglycan, the main structural component of bacterial cell walls. For this reason, expression of recombinant lytic proteins is often accompanied with lysis of the producing bacterium. This paper presents data on the construction of an inducible system for expression of the lytic peptidases AlpA and AlpB from Lysobacter sp. XL1 in Pseudomonas fluorescens Q2-87, which provides for the successful secretion of these proteins into the culture liquid. In this system, the endopeptidase gene under control of the T7lac promoter was integrated into the bacterial chromosome, as well as the Escherichia coli lactose operon repressor protein gene. The T7 pol gene under lac promoter control, which encodes the phage T7 RNA polymerase, is maintained in Pseudomonas cells on the plasmids. Media and cultivation conditions for the recombinant strains were selected to enable the production of AlpA and AlpB by a simple purification protocol. Production of recombinant lytic enzymes should contribute to the development of new-generation antimicrobial drugs whose application will not be accompanied by selection of resistant microorganisms.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000381266DOI Listing

Publication Analysis

Top Keywords

alpa alpb
12
expression lytic
8
alpb lysobacter
8
lysobacter xl1
8
lytic enzymes
8
recombinant lytic
8
lytic
5
gene
4
gene expression
4
lytic endopeptidases
4

Similar Publications

Preliminary investigation of the anti- activity of Triphala.

Front Pharmacol

November 2024

School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong, China.

Article Synopsis
  • Triphala is a combination of three botanical drugs known for its heat-clearing, anti-inflammatory, antioxidant, and antibacterial properties, extensively used in India and Tibet.
  • The study examines the antibacterial effects of Triphala on various bacteria strains using different methods, revealing its capability to inhibit bacterial growth and biofilm formation.
  • Results indicate that Triphala disrupts bacterial structure and downregulates key genes, highlighting its potential as a new therapeutic option for preventing and treating bacterial infections.
View Article and Find Full Text PDF

The primary treatment method for eradicating Helicobacter pylori (H. pylori) infection involves the use of antibiotic-based therapies. Due to the growing antibiotic resistance of H.

View Article and Find Full Text PDF
Article Synopsis
  • HZQYF, made from herbal ingredients like Chebulae Fructus, Ficus hirta, and Cloves, shows potential as an alternative treatment against a stomach bacterium linked to disorders like gastritis and gastric cancer.
  • The study evaluated HZQYF's antibacterial activity, gene expression effects, and its impact on bacterial morphology and membrane permeability using various laboratory methods.
  • Results indicate that HZQYF effectively inhibits bacterial growth and alters gene expressions critical for bacterial adhesion and activity, suggesting it could be a viable treatment option amidst rising antibiotic resistance.
View Article and Find Full Text PDF

Ethnopharmacological Relevance: Terminalia chebula Retz., known as the King of Traditional Tibetan Medicine, is widely used for treating various ailments, particularly stomach disorders. It exhibited inhibitory activity against helicobacter pylori.

View Article and Find Full Text PDF
Article Synopsis
  • Infection with Helicobacter pylori is linked to gastric cancer and biofilms help protect it from antibiotic treatment, reducing therapy effectiveness.
  • A study involving 56 strains from Bangladeshi patients classified them as 19.6% high-biofilm formers and 81.4% low-biofilm formers, with no specific clade associations found.
  • Significant SNPs in several genes, particularly alpB, were associated with high biofilm formation, indicating their potential role in detecting mutations related to biofilm development.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!